Benzinga | Oct 8, 2021 08:05AM EDT

Intra-Cellular Therapies Will Host A Virtual Event To Discuss Co.'s Pipeline Wednesday, Oct. 20 From 12:30-3:30 p.m. EDT

Virtual event to include discussions on our lumateperone, ITI-1284, PDE1 inhibitors and ITI-333 platforms

Webcast scheduled for Wednesday, Oct. 20 from 12:30 to 3:30 p.m. ET

NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a virtual event to discuss the Company's robust pipeline including lumateperone, ITI-1284, PDE inhibitor platform and ITI-333. The virtual event will take place on Wednesday, October 20, 2021, beginning at 12:30 p.m. ET. and will feature presentations and discussion from the Company's management team and external key opinion leaders.

The live and archived webcast can be accessed under "Events & Presentations" on the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.